Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor

Journal of Alzheimer's Disease

Volumn 23, Issue 4, 2011, Pages 599-605

  Banks, William A ^a   Kumar, Vijaya B ^b   Farr, Susan A ^b   Nakaoke, Ryota ^c   Robinson, Sandra M ^b   Morley, John E ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; amyloid protein precursor; antisense; blood brain barrier; bulk flow; SAMP8

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; DISEASE MODEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 79953282242     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100021     Document Type: Article

References (55)

1. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193. (Pubitemid 39348839)
2. Zlokovic BV, Yamada S, Holtzman D, Ghiso J, Frangione B (2000) Clearance of amyloid ß-peptide from brain: transport or metabolism? Nat Med 6, 718-719. (Pubitemid 30469391)
3. Zlokovic BV (2004) Clearing amyloid through the blood-brain barrier. J Neurochem 89, 807-811. (Pubitemid 38684728)
4. Banks WA, Kastin AJ, Maness LM, Banks MF, Shayo M (1997) Interactions of beta-amyloids with the blood-brain barrier. Ann N Y Acad Sci 826, 190-199.
5. Ghersi-Egea JF, Gorevic PD, Ghiso J, Frangione B, Patlak CS, Fenstermacher JD (1996) Fate of cerebrospinal fluid-borne amyloid ß-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J Neurochem 67, 880-883. (Pubitemid 26255689)
6. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer's amyloid-ß 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106, 1489-1499. (Pubitemid 32038587)
7. DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-ß efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264.
8. Bading JR, Yamada S, Mackic JB, Kirkman L, Miller C, Calero M, Ghiso J, Frangione B, Zlokovic BV (2002) Brain clearance of Alzheimer's amyloid-ß40 in the squirrel mon-key: A SPECT study in a primate model of cerebral amyloid angiopathy. J Drug Target 10, 359-368. (Pubitemid 34746318)
9. Pluta R, Misicka A, Barcikowska M, Spisacka S, Lipkowski AW, Januszewski S (2000) Possible reverse transport of beta-amyloid peptide across the blood-brain barrier. Acta Neurochir Suppl 76, 73-77.
10. Banks WA, Robinson SM, Verma S, Morley JE (2003) Efflux of human and mouse amyloid ß proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease. Neuroscience 121, 487-492. (Pubitemid 37176936)
11. Tanzi RE, Moir RD, Wagner SL (2004) Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 43, 608.
12. Lam FC, Liu R, Shapiro AB, Renoir JM, Sharon FJ, Reiner PB (2001) Beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem 76, 1121-1128.
13. Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, Kunert-Keil C, Walker LC, Warzok RW (2002) Deposition of Alzheimer's beta-amyloid is inversely correlated with p-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12, 535-541. (Pubitemid 35177083)
14. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic B (2004) LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43, 333-344. (Pubitemid 39061126)
15. Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 112, 405-415. (Pubitemid 44469161)
16. Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-DeMotta MA, Lynch JL, Robinson SM, Niehoff ML, Johnson SN, Kumar VB, Banks WA (2009) Testing the neurovascularhypothesis of Alzheimer's disease: LRP-1 anti-sense reduces blood-brain barrier clearance and increases brain levels of amyloid beta protein and impairs cognition. J Alzheimers Dis 17, 553-570.
17. Davson H, Segal MB (1996) The return of the cerebrospinal fluid to the blood: the drainage mechanism. In Physiology of the CSFand Blood-Brain Barriers, Davson H, Segal MB, eds. CRC Press, Boca Raton, pp. 489-523.
18. Silverberg GD, Heit G, Huhn S, Jaffe RA, Chang SD, Bronte-Stewart H, Rubenstein E, Possin K, Saul TA (2001) The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology 57, 1763-1766. (Pubitemid 33096680)
19. Silverberg GD, Levinthal E, Sullivan EV, Bloch DA, Chang SD, Leverenz J, Flitman S, Winn R, Marciano F, Saul T, Huhn S, Mayo M, McGuire D (2002) Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 59, 1139-1145. (Pubitemid 35192382)
20. May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI (1990) Cerebrospinal fluid production is reduced in healthy aging. Neurology 40, 500-503. (Pubitemid 20117538)
21. Kumar VB, Farr SA, Flood JF, Kamlesh V, Franko M, Banks WA, Morley JE (2000) Site-directed antisense oligonu-cleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides 21, 1769-1775. (Pubitemid 32058851)
22. Morley JE, Farr SA, Kumar VB, Banks WA (2002) Alzheimer's disease through the eye of a mouse: Acceptance lecture for the 2001 Gayle A Olson and Richard D Olson prize. Peptides 23, 589-599. (Pubitemid 34143278)
23. Morley JE, Kumar VB, Bernardo AF, Farr SA, Uezu K, Tumosa N, Flood JF (2000) ß-Amyloid precursor polypep-tide in SAMP8 mice affects learning and memory. Peptides 21, 1761-1767. (Pubitemid 32058850)
24. Kumar VB, Vyas K, Franko M, Choudhary V, Buddhiraju C, Alvarez J, Morley JE (2000) Molecular cloning, expression and regulation of hippocampal amyloid precursor protein of senescence accelerated mouse (SAMP8). Biochem Cell Biol 79, 57-67. (Pubitemid 32150976)
25. Flood JF, Morley JE (1998) Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 22, 1-20. (Pubitemid 28082281)
26. Kumar VB, Wyas K, Buddhiraju M, Alshaher M, Flood JF, Morley JE (1999) Changes in membrane fatty acids and delta-9 desaturase in senescence accelerated (SAMP8) mouse hippocampus with aging. Life Sci 65, 1657-1662. (Pubitemid 29481246)
27. Flood JF, Morley JE (1992) Early onset of age-related impair-ment of aversive and appetitive learning in the SAM-P/8 mouse. J Gerontol 47, B52-B59.
28. Flood JF, Morley JE (1994) Age-related changes in the phar-macological improvement of retention in SAMP8 mice. In The SAM Model ofSenescence, Takeda T, ed. Excerpta Med-ica, Kyoto, pp. 89-94.
29. Flood JF, Harris FJ, Morley JE (1996) Age-related changes in hippocampal drug facilitation of memory processing in SAMP8 mice. Neurobiol Aging 17, 15-24. (Pubitemid 26019092)
30. Poon HF, Castegna A, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, Klein JB, Butterfield DA (2004) Quan-titative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126, 915-926. (Pubitemid 38780896)
31. Banks WA, Farr SA, Butt W, Kumar VB, Franko MW, Morley JE (2001) Delivery across the blood-brain barrier of anti-sense directed againt amyloid ß: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein. J Pharmacol Exp Therap 297, 1113-1121. (Pubitemid 32472511)
32. Farr SA, Banks WA, Uezu K, Sano A, Gaskin FS, Morley JE (2003) Antibody to beta-amyloid protein increases acetyl-choline in the hippocampus of 12 month SAMP8 male mice. Life Sci 73, 555-562. (Pubitemid 36589035)
33. Poon HF, Farr SA, Banks WA, Pierce WM, Klein JB, Morley JE, Butterfield DA (2005) Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. Mol Brain Res 138, 8-13.
34. Poon HF, Joshi G, Sultana R, Farr SA, Banks WA, Morley JE, Calabrese V, Butterfield DA (2004) Antisense directed at the A-beta region of APP decreases brain oxidative mark-ers in aged senescence accelerated mice. Brain Res 1018, 86-96. (Pubitemid 38942865)
35. Banks WA, Kastin AJ (1989) Quantifying carrier-mediated transport of peptides from the brain to the blood. In Methods in Enzymology, Conn PM, ed. Academic Press, San Diego, vol 168, pp. 652-660. (Pubitemid 19136113)
36. Banks WA, Fasold MB, Kastin AJ (1997) Measurement of efflux rate from brain to blood. In Methods in Molecular Biol-ogy: Neuropeptides Protocols, Irvine GB, Williams CH, eds. Humana Press, Totowa, NJ, pp. 353-360.
37. Banks WA, Broadwell RD (1994) Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin and albumin: pharmacokinetic and morphological assessments. J Neurochem 62, 2404-2419. (Pubitemid 24179525)
38. Cashion MF, Banks WA, Kastin AJ (1996) Sequestra-tion of centrally administered insulin by the brain: effects of starvation, aluminum, and TNF-α. Horm Behav 30, 280-286. (Pubitemid 26356915)
39. Flood JF, Morley JE, La Reginna M (1993) Age-related changes in the pharmacological improvement of retention in senescence accelerated mouse (SAM). Neurobiol Aging 14, 159-166. (Pubitemid 23103768)
40. Poon HF, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, Butterfield DA (2005) Proteomic analy-sis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int 46, 159-168. (Pubitemid 41556623)
41. Boulton M, Flessner M, Armstrong D, Mohamed R, Hay J, Johnston M (1999) Contribution of extracranial lymphatics and arachnoid villi to the clearance of a CSF tracer in the rat. Am J Physiol 276, R818-R823. (Pubitemid 29157512)
42. Ito S, Ohtsuki S, Terasaki T (2006) Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier. Neurosci Res 56, 246-252. (Pubitemid 44572534)
43. Banks WA, Kumar VB, Morley JE (2004) Influence ofethanol dependence and methionine enkephalin antisense on serum endomorphin-1 and methionine enkephalin levels. Alcohol Clin Exp Res 28, 792-796. (Pubitemid 38661378)
44. Durham DA, Banks WA, Kastin AJ (1991) Carrier-mediated transport of labeled oxytocin from brain to blood. Neuroendocrinology 53, 447-452.
45. Kastin AJ, Fasold MB, Zadina JE (2002) Endomorphins, Metenkephalin, Tyr-MIF-1 and the P-glycoprotein efflux system. Drug Metab Disposition 30, 231-234. (Pubitemid 34175011)
46. Martins JM, Banks WA, Kastin AJ (1997) Acute modulation of the active carrier-mediated brain to blood transport of corticotropin-releasing hormone. Am J Physiol 272, E312-E319.
47. TM peptides for treatment of central nervous system neurodegeneration. J Pharmacol Exp Therap 293, 403-409. (Pubitemid 30244088)
48. Maness LM, Banks WA, Zadina JE, Kastin AJ (1996) Periventricular penetration and disappearance of ICV Tyr-MIF-1, DAMGO, tyrosine, and albumin. Peptides 17, 247-250. (Pubitemid 26124404)
49. Maness LM, Kastin AJ, Farrell CL, Banks WA (1998) Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology 139, 4556-4562. (Pubitemid 28487772)
50. Segal MB, Preston JE, Collis CS, Zlokovic BV (1990) Kinetics and Na independence of amino acid uptake by blood side of perfused sheep choroid plexus. Am J Physiology 258, F1288-F1294. (Pubitemid 20185266)
51. Banks WA, Kastin AJ (1992) Bidirectional passage of pep-tides across the blood-brain barrier. In Circumventricular Organs and Brain Fluid Environment, A Ermisch RL, Ruhle H-J, eds. Elsevier, Amsterdam, pp. 139-148.
52. Preston JE (2001) Aging choroid plexus-cerebrospinal fluid system. Microsc Res Techn 52, 31-37. (Pubitemid 32065026)
53. Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, Butterfield DA, Morley JE (2003) The antioxi-dants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 84, 1173-1183. (Pubitemid 36330669)
54. Xie R, Hammarlund-Udenaes M, De Boer AG, de Lange EC (1999) The role of P-glycoprotein in blood-brain bar-rier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice. Br J Pharmacol 128, 563-568. (Pubitemid 29504744)
55. Michaelis ML, Ansar S, Chen Y, Reiff ER, Seyb KI, Himes RH, Audus KL, Georg GI (2005) ß-amyloid-induced neurodegeneration and protection by structurally diverse microtuble-stabilizing agents. J Pharmacol Exp Therap 312, 659-668. (Pubitemid 40189564)